Who owns PDL BioPharma?

Key details on PDL BioPharma (Ticker: PDLI)

Who owns PDL BioPharma?

Is PDLI a good stock to own? Find out who bought PDL BioPharma, who sold PDL BioPharma (PDLI) stock, and who holds a large position in PDL BioPharma.

Fund Name Number of Shares Share Valuation As Of
Renaissance Technologies 11.86M $98.55M March 31, 2014
BlackRock Fund Advisors 11.51M $95.66M March 31, 2014
Vanguard 9.96M $82.75M March 31, 2014
Schroder Investment Management 8.80M $73.10M March 31, 2014
Baupost 8.00M $49.60M Dec. 31, 2011
Acadian Asset Management 6.49M $62.79M June 30, 2014
FMR 6.37M $49.20M June 30, 2013
BlackRock Institutional Trust Company, N.A. 4.65M $38.67M March 31, 2014
STATE STREET CORPORATION 3.66M $30.44M March 31, 2014
Gotham Asset Management 3.34M $28.22M Dec. 31, 2013
Advisors Asset Management 3.34M $28.21M Dec. 31, 2013
Inves 3.25M $27.00M March 31, 2014
AQR Capital Management 2.98M $22.97M June 30, 2013
MSDC Management 2.86M $18.94M June 30, 2012
OppenheimerFunds 2.82M $18.71M June 30, 2012
Two Sigma Advisers 2.80M $21.52M Sept. 30, 2012
DIMENSIONAL FUND ADVISORS 2.72M $22.62M March 31, 2014
Wells Fargo & Company 2.69M $22.32M March 31, 2014
NORTHERN TRUST 2.64M $21.77M March 31, 2014
Bank of America Corporation 2.64M $21.91M March 31, 2014
NUMERIC INVESTORS 2.42M $20.40M Dec. 31, 2013
Hussman Econometrics Advisors 2.22M $17.68M Sept. 30, 2013
Two Sigma Investments 2.17M $15.86M March 31, 2013
Frank Russell Company 2.11M $17.50M March 31, 2014
ARONSON JOHNSON ORTIZ 2.06M $17.09M March 31, 2014
First Trust Advisors 2.00M $14.11M Dec. 31, 2012
LSV Asset Management 1.97M $16.39M March 31, 2014

Who sold PDL BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
Jacobs Levy Equity Management June 30, 2011 2.06M $12.07M
First Eagle Investment Management Dec. 31, 2010 3.55M $22.12M
Gail Mannix Dec. 31, 2010 1.93M $12.03M
Paulson & Co March 31, 2008 5.40M $57.16M
Tudor Investment Corporation March 31, 2006 1.96M $64.31M